Takeda Executive and Leadership Team

Milano Furuta, the Chief Financial Officer & Director at Takeda, oversees the financial health and capital allocation strategies of the global pharmaceutical organization. Furuta directs fiscal planning, risk management, and investor relations to support the company's extensive research and development pipeline. Milano Furuta evaluates investment opportunities in gastroenterology, oncology, and neuroscience to ensure sustainable growth and long-term value creation. As a member of the board, the Chief Financial Officer & Director provides critical insights into market trends and economic conditions affecting the healthcare sector. This leadership role involves managing complex financial reporting requirements and ensuring compliance with international regulatory standards. By optimizing the capital structure and driving cost-efficiency across manufacturing operations, Furuta secures the resources necessary for innovation. The Chief Financial Officer & Director maintains the financial stability required to advance plasma-derived therapies and vaccines on a global scale.

Laura Pasternak, the Chief of Staff at Takeda, coordinates high-level strategic initiatives across the global pharmaceutical enterprise. Pasternak aligns executive priorities with the long-term research and development goals of the organization. By facilitating communication between senior leadership and departmental heads, the Chief of Staff ensures operational cohesion in the pursuit of breakthrough therapies. Laura Pasternak manages complex project workflows that support the company's mission in gastroenterology and oncology. This role involves synthesizing data from various business units to inform decision-making processes at the board level. Through rigorous oversight of internal governance, the Chief of Staff maintains the integrity of corporate objectives. Pasternak drives efficiency by streamlining cross-functional collaboration, ultimately enabling the firm to address unmet medical needs in rare diseases and neuroscience with greater agility and precision.

Yuko Barnaby, the Executive Assistant To Nicola Greenway, Chief Human Resources Officer at Takeda, manages the administrative infrastructure supporting the global human capital strategy. Barnaby optimizes the daily operations of the human resources division to ensure alignment with the broader pharmaceutical research and manufacturing goals. Yuko Barnaby facilitates critical interactions between the Chief Human Resources Officer and key stakeholders, fostering an environment of organizational excellence. This position requires meticulous attention to detail regarding talent management, workforce planning, and internal policy implementation. By coordinating complex schedules and high-priority communications, the Executive Assistant To Nicola Greenway, Chief Human Resources Officer enables the leadership team to focus on scaling the company's global footprint. Barnaby supports the development of inclusive workplace initiatives that empower employees to contribute effectively to the discovery and delivery of life-saving medicines across diverse therapeutic areas.

Emily Welch, the HR Leader & Chief of Staff at Takeda, integrates human capital strategy with operational execution to drive organizational performance. Welch oversees talent development programs that support the company's research-intensive business model. Emily Welch coordinates cross-functional teams to ensure that human resources initiatives align with the strategic goals of the gastroenterology and oncology divisions. This role involves managing internal communications and leadership development to foster a culture of innovation and compliance. By bridging the gap between executive strategy and workforce implementation, the HR Leader & Chief of Staff enhances operational efficiency across the global organization. Welch monitors key performance indicators related to employee engagement and organizational health. Through the application of data-driven insights, the HR Leader & Chief of Staff ensures that the company maintains the specialized talent required to lead in the competitive pharmaceutical landscape.

Amy Palmieri, the Strategic Programs Lead & , Usbu Foundational Therapeutics Platform Chief of Staff at Takeda, manages the execution of critical initiatives within the foundational therapeutics division. Palmieri directs the planning and implementation of programs that support the development of plasma-derived therapies and rare disease treatments. Amy Palmieri coordinates with research and manufacturing teams to ensure that strategic objectives are met within established timelines. This role involves identifying operational bottlenecks and implementing solutions that enhance the efficiency of the therapeutics platform. By aligning project goals with the company's broader mission, the Strategic Programs Lead & , Usbu Foundational Therapeutics Platform Chief of Staff facilitates seamless collaboration across departments. Palmieri monitors program progress and reports findings to senior leadership to inform future investment decisions. Through rigorous project management, the Strategic Programs Lead & , Usbu Foundational Therapeutics Platform Chief of Staff drives the successful delivery of essential healthcare products to patients worldwide.

Robert Futhey, the Msat Data Specialist & Chief Marketing Officer at Takeda, directs the commercial strategy and data-driven marketing efforts for the company's pharmaceutical portfolio. Futhey oversees the promotion of products in gastroenterology, oncology, and neuroscience, ensuring that market positioning reflects the clinical value of these therapies. Robert Futhey leverages advanced data analytics to identify market opportunities and optimize the reach of healthcare solutions. This role involves coordinating with the manufacturing and science teams to translate technical product benefits into compelling market narratives. By analyzing patient needs and physician feedback, the Msat Data Specialist & Chief Marketing Officer shapes the commercial trajectory of new and existing medicines. Futhey drives brand awareness and market penetration across diverse global regions. The Msat Data Specialist & Chief Marketing Officer ensures that marketing campaigns remain compliant with regulatory standards while effectively communicating the impact of the company's innovative research.

Christopher Williams, the Head Chief Technology Officer, Devsecops Office of at Takeda, architects the digital infrastructure and security frameworks necessary for modern pharmaceutical research. Williams directs the implementation of DevSecOps practices to ensure that software development and data management processes remain secure and efficient. Christopher Williams oversees the integration of advanced technology solutions that support the company's manufacturing and clinical trial operations. This role involves managing the cybersecurity posture of the organization to protect sensitive research data and intellectual property. By fostering a culture of continuous improvement in technology, the Head Chief Technology Officer, Devsecops Office of enables the firm to accelerate the development of new therapies. Williams collaborates with cross-functional teams to deploy scalable digital tools that enhance operational productivity. The Head Chief Technology Officer, Devsecops Office of ensures that the company's technological capabilities remain at the forefront of the global healthcare industry.

Jessica Vieira, the Global Supply & Quality Chief of Staff at Takeda, coordinates the operational activities of the supply chain and quality assurance divisions. Vieira ensures that the manufacturing and distribution of pharmaceutical products meet the highest international standards for safety and efficacy. Jessica Vieira facilitates communication between supply chain managers and quality control teams to prevent disruptions in the delivery of essential medicines. This role involves overseeing the implementation of quality management systems that support the company's global operations. By streamlining processes and enhancing transparency, the Global Supply & Quality Chief of Staff drives operational excellence across the entire product lifecycle. Vieira monitors supply chain performance and quality metrics to identify areas for improvement. The Global Supply & Quality Chief of Staff ensures that the company maintains a robust and reliable supply network capable of meeting the needs of patients in diverse markets.

Swarup Shetty, the Director, Business Excellence & Global Regulatory Operations Chief of Staff at Takeda, manages the intersection of operational efficiency and regulatory compliance. Shetty directs initiatives that optimize business processes within the regulatory affairs department to ensure timely product approvals. Swarup Shetty coordinates with global teams to navigate complex regulatory landscapes, facilitating the market entry of new pharmaceutical products. This role involves implementing best practices in business excellence to improve the speed and quality of regulatory submissions. By aligning operational workflows with global standards, the Director, Business Excellence & Global Regulatory Operations Chief of Staff supports the company's mission to deliver innovative healthcare solutions. Shetty monitors regulatory trends and internal performance to drive continuous improvement. The Director, Business Excellence & Global Regulatory Operations Chief of Staff ensures that the organization maintains the highest level of compliance while achieving its strategic growth objectives in the global pharmaceutical market.

Tracy Page, the Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management at Takeda, oversees the integration of agile methodologies with ethical and compliance standards across the global portfolio. Page directs the management of the company's research and development pipeline, ensuring that project selection aligns with strategic priorities and ethical guidelines. Tracy Page facilitates cross-functional collaboration to enhance the agility of operations, allowing the firm to respond rapidly to changing market conditions. This role involves maintaining rigorous compliance frameworks that govern the development and marketing of pharmaceutical products. By balancing portfolio management with operational efficiency, the Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management ensures that the company delivers value to patients while upholding the highest standards of integrity. Page monitors portfolio performance and compliance metrics to guide decision-making. The Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management drives the successful execution of the company's long-term research strategy.